SavedAdd your journal

Journals / Pamukkale Üniversitesi Mühendislik Bilimleri Dergisi / 2017 / Cilt: 23 - Sayı: 7

Probiotic Escherichia coli Strain Nissle 1917

Probiyotik Escherichia coli Suşu Nissle 1917

Seda ALTUNTAŞ
Mihriban KORUKLUOĞLU
Volkan ALTUNTAŞ
Pages
933–940
Publication Date
2017-12-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, clinical trials conducted with EcN (Escherichia coli Nissle 1917) will be summarized.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Probiotics are live microorganisms that confer a health benefit on the host when administered in adequate amounts.
📊
Key Findings & Data:In livestock breeding, feed industry and pharmaceutical industry, microorganisms which are non-pathogenic and have positive effects on health (Sacchromyces boulardii, and Escherichia coli Nissle 1917) are used besides the lactic acid bacteria.
💡
Conclusion & Impact:Additionally, clinical trials conducted with EcN (Escherichia coli Nissle 1917) will be summarized.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:E. coli suşu Nissle 1917 · EcN · Probiyotikler

Abstract

Probiotics are live microorganisms that confer a health benefit on the host when administered in adequate amounts. Probiotic microorganisms are usually components of foods such as fermented dairy products or food supplements. In the food industry, Lactic Acid Bacteria (LAB) is widely used. In livestock breeding, feed industry and pharmaceutical industry, microorganisms which are non-pathogenic and have positive effects on health (Sacchromyces boulardii, and Escherichia coli Nissle 1917) are used besides the lactic acid bacteria. This review focused on origin, medical history, microbiological and genetic characteristics, biological activity, biosafety and toxicological aspects of probiotic E. coli strain Nissle 1917. Additionally, clinical trials conducted with EcN (Escherichia coli Nissle 1917) will be summarized.

Özet

Probiyotikler yeterli miktarda alındıklarında, konakçının sağlığı üzerine olumlu etkileri bulunan, patojen olmayan canlı mikroorganizmalardır. Probiyotik mikroorganizmalar genellikle fermente süt ürünleri veya gıda takviyeleri gibi gıda maddelerinin bileşenleridir. Gıda endüstrisinde, yaygın olarak Laktik Asit Bakterileri (LAB) kullanılmaktadır. Hayvan besleme, yem endüstrisi ve ilaç sanayiinde ise laktik asit bakterilerinin yanı sıra diğer patojen olmayan ve sağlık üzerine olumlu etkileri bulunan mikroorganizmalar da (Sacchromyces boulardii ve Escherichia coli Nissle 1917 ) kullanılır. Bu çalışmada; probiyotik E. coli suşu Nissle 1917’nin kökeni, tıbbi tarihi, mikrobiyolojik ve genetik özellikleri, biyolojik aktiviteleri, güvenirliliği ve toksikolojik yönü ele alınmıştır. Bunlara ek olarak EcN (E.coli Nissle 1917) ile yapılan klinik deneyler de özetlenecektir.

🔖

Cite This Article

ALTUNTAŞ, S., KORUKLUOĞLU, M., ALTUNTAŞ, V. (2017). Probiotic Escherichia coli Strain Nissle 1917. Pamukkale Üniversitesi Mühendislik Bilimleri Dergisi, Cilt: 23 - Sayı: 7, 933–940. https://ajindex.com/articles/42460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Yaşar B, Kurdaş OÖ. "Probiyotikler ve gastrointestinal sistem". Güncel Gastroenteroloji, 13(1), 23-28, (2009).
  2. Sonnenborn U, Jürgen S. "The non-pathogenic Escherichia coli strain Nissle 1917-features of a versatile probiotic". Microbial Ecology in Health and Disease, 21(3-4), 122-158, 2009.
  3. Fuller R. “Probiotics in man and animals”. Journal of Applied Bacteriology, 66(5), 365-378, 1989.
  4. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Relman DA. "Diversity of the human intestinal microbial flora". Science, 308(5728), 1635-1638, 2005.
  5. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. "Probiotic mechanisms of action". Annals of Nutrition and Metabolism, 61(2), 160-174, 2012. Metehan Ö. Sağlıklı Kalmak için Probiyotikler, Prebiyotikler Anlatılmayan Tarihçe. İstanbul,
  6. Türkiye, Nobel Tıp Kitapevleri, 2011.
  7. Ceyhan N, Alıç H. “Bağırsak mikroflorası ve probiyotikler”. Türk Bilimsel Derlemeler Dergisi, 5(1), 107-113, 2012.
  8. Altenhoefer A, Oswald S, Sonnenborn U, Enders C, Schulze J, Hacker J, Oelschlaeger TA. "The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens". FEMS Immunology & Medical Microbiology, 40(3), 223-229, 2004.
  9. Nami Y, Haghshenas B, Abdullah N, Barzegari A, Radiah D, Rosli R, Khosroushahi AY. "Probiotics or antibiotics: future challenges in medicine". Journal of Medical Microbiology, 64(2), 137-146, 2015.
  10. Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, Gasbarrini A. "Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update". World Journal of Gastroenterology, 22(24), 5505-5511, 2016.
  11. Konturek PC, Sliwowski Z, Koziel J, Ptak-Belowska A, Burnat G, Brzozowski T, Konturek SJ. "Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress”. Journal of Physiology and Pharmacology, 60(6), 41-48, 2009.
  12. Kruis W, Frič P, Pokrotnieks J, Lukáš M, Fixa B, Kaščák M, Wolff C. “Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine”. Gut, 53(11), 1617-1623, 2004.
  13. Kleta S, Steinru H, Breves G, Duncker S, Laturnus C, Wieler LH, Schierack P. “Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany”. Journal of Applied Microbiology, 101(6), 1357-1366